ATAI logo

Atai Life Sciences NV (ATAI) Company Overview

Profile

Full Name:

Atai Life Sciences N.V.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Germany

IPO:

June 18, 2021

Indexes:

Not included

Website:

http://www.atai.life

Description:

ATAI Life Sciences NV is a biotechnology company focused on developing innovative treatments for mental health disorders. They work on new therapies using psychedelics and other compounds to improve patient outcomes. Their goal is to transform mental health care through scientific research and collaboration.

Key Details

Price

$1.80

Market Cap

$302.04 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$314.00 K(+34.76% YoY)

Annual EPS

-$0.25(+74.49% YoY)

PE Ratio

-

Annual ROE

-15.77%

Annual Debt To Equity

0.07

Beta

1.66

Events Calendar

Earnings

Next earnings date:

May 15, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 24, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 13, 25 HC Wainwright & Co.
Buy
Nov 18, 24 HC Wainwright & Co.
Buy
Nov 18, 24 Canaccord Genuity
Buy

Screeners with ATAI included

Growing Shares Outstanding
Stocks with high beta
Most recommended stocks
Best performing stocks last 3 months
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.80
ATAI price is $1.80

Price All-time High

$19.89
ATAI price is currently -90.95% below its historical high of $19.89

Price Analysts Target

$8.00
ATAI price is currently -77.50% lower than the consensus analysts' forecast

Price Today Change

-1.64%
ATAI price is down -1.64% today

Price YTD Change

+34.33%
ATAI price is up +34.33% since January 1st

Price 3-Year Change

-67.45%
ATAI price is down -67.45% over the past 3 years

Market cap

Market Cap

$302.04 M
ATAI market capitalization is $302.04 million

Market Cap 3-Year Change

-66.01%
ATAI market capitalization is down -66.01% over the past 3 years

Market Cap All-time High

$3.03 B
ATAI market capitalization is currently -90.05% below its historical high of $3.03 billion

Market Cap Sector Rank

60.73%
ATAI market capitalization is higher than 60.73% of companies in Healthcare sector

Technical

Beta

1.66
ATAI beta is 1.66

200-day SMA

$1.46
ATAI price is currently +23.28% above its 200-day simple moving average

14-day RSI

46.62
ATAI 14-day relative strength index is 46.62

30-day Relative Volume

1.06
ATAI 30-day relative volume is 1.06

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$314.00 K
ATAI annual revenue is $314.00 thousand

Annual Revenue Analysts Estimate

$554.33 K
ATAI annual revenue is currently -43.36% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+34.76%
ATAI annual revenue is up +34.76% year-on-year

Annual Revenue Sector Rank

7.92%
ATAI annual revenue is higher than 7.92% of companies in Healthcare sector

Profit

Annual Gross Profit

-
ATAI annual gross profit value is unknown

Annual Gross Margin

-
ATAI annual gross profit margin value is unknown

Annual Operating Profit

-$123.03 M
ATAI annual operating income is -$123.03 million

Annual Operating Margin

-39.18 K%
ATAI annual operating profit margin is -39.18 thousand%

Annual Net Income

-$40.22 M
ATAI annual net profit is -$40.22 million

Annual Net Margin

-12.81 K%
ATAI annual net profit margin is -12.81 thousand%

EPS

Annual EPS

-$0.25
ATAI annual earnings per share is -$0.25

Annual EPS Analysts Estimate

-$0.76
ATAI annual earnings per share is currently -66.96% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+74.49%
ATAI annual earnings per share is up +74.49% year-on-year

Annual EPS Sector Rank

78.08%
ATAI annual earnings per share is higher than 78.08% of companies in Healthcare sector

ROA & ROE

Annual ROA

-13.43%
ATAI annual return on assets is -13.43%

Annual ROE

-15.77%
ATAI annual return on equity is -15.77%

EBIT & EBITDA

Annual EBIT

-$36.63 M
ATAI annual earnings before interest & taxes is -$36.63 million

Annual EBITDA

-$36.31 M
ATAI annual EBITDA is -$36.31 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ATAI price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ATAI price to earnings ratio is unknown

PB Ratio

PB Ratio

2.07
ATAI price to book ratio is 2.07

PB Ratio Sector Rank

59.84%
ATAI price to book ratio is higher than 59.84% of companies in Healthcare sector

PS Ratio

PS Ratio

912.52
ATAI price to sales ratio is 912.52

PS Ratio Sector Rank

98.32%
ATAI price to sales ratio is higher than 98.32% of companies in Healthcare sector

Enterprise value

Enterprise Value

$295.89 M
ATAI enterprise value is $295.89 million

Enterprise Value Sector Rank

61.58%
ATAI enterprise value is higher than 61.58% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.38
ATAI EV/EBITDA is -2.38

EV/EBITDA Sector Rank

34.39%
ATAI EV/EBITDA is higher than 34.39% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

9.22
ATAI annual current ratio is 9.22

Annual Quick Ratio

-
ATAI annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.07
ATAI annual debt to equity ratio is 0.07

Annual Interest Coverage Ratio

-13.79
ATAI annual interest coverage ratio is -13.79

Risk & Stability

Piotroski F-Score

-
ATAI piotroski f-score value is unknown

Altman Z-Score

1.32
ATAI altman z-score is 1.32

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$293.48 M
ATAI annual total assets is $293.48 million

Annual Non Current Assets

$107.89 M
ATAI annual long term assets is $107.89 million

Annual Current Assets

$185.59 M
ATAI annual total current assets is $185.59 million

Annual Cash & Cash Equivalents

$45.03 M
ATAI annual cash & cash equivalents is $45.03 million

Equity

Annual Book Value

$242.96 M
ATAI annual book value is $242.96 million

Annual Working Capital

$165.47 M
ATAI annual working capital is $165.47 million

Liabilities

Annual Total Liabilities

$49.16 M
ATAI annual total liabilities is $49.16 million

Annual Total Long Term Liabilities

$29.04 M
ATAI annual total long term liabilities is $29.04 million

Annual Current Liabilities

$20.12 M
ATAI annual total current liabilities is $20.12 million

Annual Accounts Payable

$4.59 M
ATAI annual accounts payable is $4.59 million

Debt

Annual Total Debt

$19.14 M
ATAI annual total debt is $19.14 million

Annual Total Debt 1-Year Change

+24.78%
ATAI annual total debt is up +24.78% year-on-year

Annual Long Term Debt

$18.87 M
ATAI annual long term debt is $18.87 million

Annual Short Term Debt

$275.00 K
ATAI annual short term debt is $275.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$123.34 M
ATAI annual total expenses is $123.34 million

Annual Operating Expenses

$123.34 M
ATAI annual total operating expenses is $123.34 million

Annual Cost Of Goods Sold

-
ATAI annual cost of goods sold value is unknown

Annual SGA

$63.58 M
ATAI annual SGA is $63.58 million

Annual D&A

$319.00 K
ATAI annual depreciation & amortization is $319.00 thousand

Annual Interest Expense

$2.66 M
ATAI annual interest expense is $2.66 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$84.12 M
ATAI annual cash flow from operations is -$84.12 million

Annual CFO 1-Year Change

+19.48%
ATAI annual cash flow from operations is up +19.48% year-on-year

Annual CFI

-$53.30 M
ATAI annual cash flow from investing activities is -$53.30 million

Annual CFI 1-Year Change

+38.63%
ATAI annual cash flow from investing activities is up +38.63% year-on-year

Annual CFF

-$8.36 M
ATAI annual cash flow from financing activities is -$8.36 million

Annual CFF 1-Year Change

-140.2%
ATAI annual cash flow from financing activities is down -140.2% year-on-year

Free CashFlow

Annual FCF

-$84.71 M
ATAI annual free cash flow is -$84.71 million

Annual FCF 1-Year Change

+19.7%
ATAI annual free cash flow is up +19.7% year-on-year

CAPEX

Annual CAPEX

$590.00 K
ATAI annual capital expenditures is $590.00 thousand

Annual CAPEX 1-Year Change

-42.38%
ATAI annual capital expenditures is down -42.38% year-on-year

Institutional Ownership

Similar stocks

QTRX logo
Quanterix (QTRX)
AHG logo
Akso Health (AHG)
CERS logo
Cerus (CERS)
enGene Holdings (ENGN)
TRML logo
Tourmaline Bio (TRML)
HCAT logo
Health Catalyst (HCAT)
ACB logo
Aurora Cannabis (ACB)
SMTI logo
Sanara MedTech (SMTI)
MBX Biosciences (MBX)

FAQ

  • What is the ticker symbol for Atai Life Sciences NV?
  • Does Atai Life Sciences NV pay dividends?
  • What sector is Atai Life Sciences NV in?
  • What industry is Atai Life Sciences NV in?
  • What country is Atai Life Sciences NV based in?
  • When did Atai Life Sciences NV go public?
  • Is Atai Life Sciences NV in the S&P 500?
  • Is Atai Life Sciences NV in the NASDAQ 100?
  • Is Atai Life Sciences NV in the Dow Jones?
  • When was Atai Life Sciences NV's last earnings report?
  • When does Atai Life Sciences NV report earnings?
  • Should I buy Atai Life Sciences NV stock now?

What is the ticker symbol for Atai Life Sciences NV?

The ticker symbol for Atai Life Sciences NV is NASDAQ:ATAI

Does Atai Life Sciences NV pay dividends?

No, Atai Life Sciences NV does not pay dividends

What sector is Atai Life Sciences NV in?

Atai Life Sciences NV is in the Healthcare sector

What industry is Atai Life Sciences NV in?

Atai Life Sciences NV is in the Biotechnology industry

What country is Atai Life Sciences NV based in?

Atai Life Sciences NV is headquartered in Germany

When did Atai Life Sciences NV go public?

Atai Life Sciences NV's initial public offering (IPO) was on June 18, 2021

Is Atai Life Sciences NV in the S&P 500?

No, Atai Life Sciences NV is not included in the S&P 500 index

Is Atai Life Sciences NV in the NASDAQ 100?

No, Atai Life Sciences NV is not included in the NASDAQ 100 index

Is Atai Life Sciences NV in the Dow Jones?

No, Atai Life Sciences NV is not included in the Dow Jones index

When was Atai Life Sciences NV's last earnings report?

Atai Life Sciences NV's most recent earnings report was on Nov 13, 2024

When does Atai Life Sciences NV report earnings?

The next expected earnings date for Atai Life Sciences NV is May 15, 2025

Should I buy Atai Life Sciences NV stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions